Biotech Growth N V - Oct 19, 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role: 10%+ Owner
Signature: /s/ Daniel Koller
Stock symbol: BDTX
Transactions as of: Oct 19, 2022
Transactions value $: $179,120
Form type: 4
Date filed: 10/21/2022, 03:06 PM
Previous filing: Jul 20, 2022
Next filing: Oct 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDTX	Common Stock	Purchase	$103K	+77.7K	+1.66%	$1.32	4.77M	Oct 19, 2022	Direct
transaction	BDTX	Common Stock	Purchase	$76.3K	+53.7K	+1.13%	$1.42	4.83M	Oct 20, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.